What is HC Wainwright’s Estimate for GALT Q2 Earnings?
Galectin Therapeutics Inc. (NASDAQ:GALT – Free Report) – Equities researchers at HC Wainwright issued their Q2 2025 EPS estimates for Galectin Therapeutics in a report issued on Tuesday, June 17th. HC Wainwright analyst M. Keller forecasts that the company will earn ($0.16) per share for the quarter. HC Wainwright has a “Buy” rating and a […]
Galectin Therapeutics Inc. (NASDAQ:GALT – Free Report) – Equities researchers at HC Wainwright issued their Q2 2025 EPS estimates for Galectin Therapeutics in a report issued on Tuesday, June 17th. HC Wainwright analyst M. Keller forecasts that the company will earn ($0.16) per share for the quarter. HC Wainwright has a “Buy” rating and a […]
